12:00 AM
 | 
Dec 17, 2007
 |  BioCentury  |  Regulation

Kynapid cardioversion

Kynapid cardioversion

Kynapid cardioversion
Patients in the Kynapid Phase III trials received an initial infusion of 3 mg/kg over 10 minutes. If conversion to normal sinus rhythm did not occur within 15 minutes of the completion of the first dose, a second infusion of 2 mg/kg was administered...

Read the full 243 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >